Pharma industry committed to supplying quality drugs in India, world: IPA
Published on 9 July, 2020 / Published by Business Standard

IPA Secretary General Jain said, the Indian pharmaceutical industry has outshone itself as a consistent and reliable supplier of life-saving medicines to India and the world. Indian pharma industry is committed to an uninterrupted supply of quality medicines to patients in India and globally, Indian Pharmaceutical Alliance (IPA) said on Thursday.

The Prime Minister's speech at the India Global Week 2020 captures the strength of India's pharma industry. During these unprecedented times, the pharmaceutical industry worked in an integrated manner with the Indian government to ensure fulling domestic demand and meet export obligations and truly lived up to its title as the 'Pharmacy of the World'," IPA Secretary General Sudarshan Jain said in a statement. Prime Minister Narendra Modi in his inaugural address at the India Global Week 2020 said the pandemic has once again shown that India's pharma industry is an asset not just for India but for the entire world.

"It has played a leading role in reducing the cost of medicines especially for the developing countries," he added. Jain said time and again, the Indian pharmaceutical industry has outshone itself as a consistent and reliable supplier of life-saving medicines to India and the world. "At a time when the world was grappling to ease out supply chain disruptions as a result of the lockdown, Indian pharma industry collectively rose to the challenge and assured uninterrupted supply of medicines to several countries to aid their ght against Covid-19," he added. When the industry makes a shift towards self-reliance, international collaborations will add much needed Impetus to the vision of providing access to quality medicines, Jain said.

This article was originally published on Business Standard